Private area
Contact Us
Total Visits
| Views | |
|---|---|
| First-in-human, ... | 119 |
Total Visits Per Month
| June 2025 | July 2025 | August 2025 | September 2025 | October 2025 | November 2025 | December 2025 | |
|---|---|---|---|---|---|---|---|
| First-in-human, ... | 1 | 10 | 1 | 2 | 4 | 4 | 1 |
File Visits
| Views | |
|---|---|
| first_in_human_open_label_phase_1_2_study_monoclonal_antibody_programmed_cell_death_protein_1_PD_1_inhibitor_cetrelimab_jnj_63723283_patients_advanced_cancers_2022.pdf | 82 |
Top country views
| Views | |
|---|---|
| United States | 34 |
| Spain | 16 |
| Singapore | 14 |
| China | 11 |
| Hong Kong | 9 |
| Brazil | 6 |
| Germany | 6 |
| Vietnam | 5 |
| Finland | 3 |
| United Kingdom | 3 |
Top cities views
| Views | |
|---|---|
| Singapore | 12 |
| Hong Kong | 9 |
| Barcelona | 8 |
| Beijing | 8 |
| Ashburn | 5 |
| Boydton | 4 |
| Dublin | 2 |
| Hanoi | 2 |
| Ho Chi Minh City | 2 |
| London | 2 |
